CPT2 and limb-girdle muscular dystrophy: When testing a patient who has an LGMD phenotype, apart from the usual LGMD genes, the panel should also include genes that cause metabolic myopathies that may present with a fixed LGMD phenotype such as acid alpha-glucosidase deficiency, CPT2 deficiency, and McArdle disease (83, 85).